Cargando…
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
Continuous subcutaneous (SubQ) treprostinil is an effective therapy for pediatric patients diagnosed with pulmonary hypertension (PH). To date, the clinical characteristics and factors associated with failure to tolerate this therapy have not been described. The purpose was to describe patient‐repor...
Autores principales: | McSweeney, Julia, Colglazier, Elizabeth, Becerra, Jasmine, Leary, Brienne, Miller‐Reed, Kathleen, Walker, Stephen, Tillman, Katy, Magness, Melissa, Ogawa, Michelle, Bannon, Whitney, Kivett, Tisha, Jackson, Emma O., Davis, Anne, Shepard, Cathy, Richards, Susan, Whalen, Elise, Engstrand, Shannon, DiPasquale, Zachary, Connor, Jean A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151594/ https://www.ncbi.nlm.nih.gov/pubmed/37143765 http://dx.doi.org/10.1002/pul2.12224 |
Ejemplares similares
-
Pediatric subcutaneous treprostinil site maintenance and pain control strategies from the Pediatric Pulmonary Hypertension Network
por: Jackson, Emma O., et al.
Publicado: (2021) -
Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2018) -
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
por: Chapman, Richard W., et al.
Publicado: (2021) -
Real-world evidence of subcutaneous treprostinil use in pulmonary arterial hypertension in Argentina
por: Lescano, Adrián, et al.
Publicado: (2022) -
Subcutaneous use of treprostinil in pediatric pulmonary hypertension patients: A report of three cases
por: Kavgacı, Akif, et al.
Publicado: (2023)